Eloxx Pharmaceuticals, Inc. (ELOX)
Nasdaq: ELOX · CIK 0001035354 · United States
Every official Eloxx Pharmaceuticals, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open ELOX filings
Eloxx Pharmaceuticals, Inc. documents
- Eloxx Pharmaceuticals, Inc. 10-K 2026ELOX 10-K 2026: annual report for fiscal 2026
- Eloxx Pharmaceuticals, Inc. 10-K 2025ELOX 10-K 2025: annual report for fiscal 2025
- Eloxx Pharmaceuticals, Inc. 10-K 2024ELOX 10-K 2024: annual report for fiscal 2024
- Eloxx Pharmaceuticals, Inc. 10-K 2023ELOX 10-K 2023: annual report for fiscal 2023
- Eloxx Pharmaceuticals, Inc. 10-K 2022ELOX 10-K 2022: annual report for fiscal 2022
- Eloxx Pharmaceuticals, Inc. 10-Q 2026ELOX 10-Q 2026: quarterly report for fiscal 2026
- Eloxx Pharmaceuticals, Inc. 10-Q 2025ELOX 10-Q 2025: quarterly report for fiscal 2025
- Eloxx Pharmaceuticals, Inc. 10-Q 2024ELOX 10-Q 2024: quarterly report for fiscal 2024
- Eloxx Pharmaceuticals, Inc. 10-Q 2023ELOX 10-Q 2023: quarterly report for fiscal 2023
- Eloxx Pharmaceuticals, Inc. 10-Q 2022ELOX 10-Q 2022: quarterly report for fiscal 2022
- Eloxx Pharmaceuticals, Inc. 8-K 2026ELOX 8-K 2026: current report for fiscal 2026
- Eloxx Pharmaceuticals, Inc. 8-K 2025ELOX 8-K 2025: current report for fiscal 2025
- Eloxx Pharmaceuticals, Inc. 8-K 2024ELOX 8-K 2024: current report for fiscal 2024
- Eloxx Pharmaceuticals, Inc. 8-K 2023ELOX 8-K 2023: current report for fiscal 2023
- Eloxx Pharmaceuticals, Inc. 8-K 2022ELOX 8-K 2022: current report for fiscal 2022
- Eloxx Pharmaceuticals, Inc. DEF 14A 2026ELOX DEF 14A 2026: proxy statement for fiscal 2026
- Eloxx Pharmaceuticals, Inc. DEF 14A 2025ELOX DEF 14A 2025: proxy statement for fiscal 2025
- Eloxx Pharmaceuticals, Inc. DEF 14A 2024ELOX DEF 14A 2024: proxy statement for fiscal 2024
- Eloxx Pharmaceuticals, Inc. DEF 14A 2023ELOX DEF 14A 2023: proxy statement for fiscal 2023
- Eloxx Pharmaceuticals, Inc. DEF 14A 2022ELOX DEF 14A 2022: proxy statement for fiscal 2022
- Eloxx Pharmaceuticals, Inc. Form 4 2026ELOX Form 4 2026: insider trading filing for fiscal 2026
- Eloxx Pharmaceuticals, Inc. Form 4 2025ELOX Form 4 2025: insider trading filing for fiscal 2025
- Eloxx Pharmaceuticals, Inc. Form 4 2024ELOX Form 4 2024: insider trading filing for fiscal 2024
- Eloxx Pharmaceuticals, Inc. Form 4 2023ELOX Form 4 2023: insider trading filing for fiscal 2023
- Eloxx Pharmaceuticals, Inc. Form 4 2022ELOX Form 4 2022: insider trading filing for fiscal 2022
- Eloxx Pharmaceuticals, Inc. S-1 2026ELOX S-1 2026: registration statement for fiscal 2026
- Eloxx Pharmaceuticals, Inc. S-1 2025ELOX S-1 2025: registration statement for fiscal 2025
- Eloxx Pharmaceuticals, Inc. S-1 2024ELOX S-1 2024: registration statement for fiscal 2024
- Eloxx Pharmaceuticals, Inc. S-1 2023ELOX S-1 2023: registration statement for fiscal 2023
- Eloxx Pharmaceuticals, Inc. S-1 2022ELOX S-1 2022: registration statement for fiscal 2022
- Eloxx Pharmaceuticals, Inc. 13F 2026ELOX 13F 2026: institutional holdings for fiscal 2026
- Eloxx Pharmaceuticals, Inc. 13F 2025ELOX 13F 2025: institutional holdings for fiscal 2025
- Eloxx Pharmaceuticals, Inc. 13F 2024ELOX 13F 2024: institutional holdings for fiscal 2024
- Eloxx Pharmaceuticals, Inc. 13F 2023ELOX 13F 2023: institutional holdings for fiscal 2023
- Eloxx Pharmaceuticals, Inc. 13F 2022ELOX 13F 2022: institutional holdings for fiscal 2022
More companies